Browse

You are looking at 51 - 60 of 1,131 items for

  • Refine by Content Type: News x
Clear All Modify Search

More than most—if not all—other medical disciplines, nephrology nurses act as advocates to ensure our patients live their best possible lives. 

Reaffirming that race is a social, not a biological, construct, ASN remains committed to ensuring that racial and ethnic biases do not affect the diagnosis and treatment of kidney diseases.

The American Society of Nephrology (ASN) seeks nominations for the annual election of the ASN Council, the society's governing board. Qualified candidates should have the vision, experience, and expertise to guide the society in leading the fight against kidney diseases.

Nephrology, more than any other specialty in medicine, was built on innovation. The artificial kidney-imagined, invented, and implemented by pioneers in our field-is nothing short of miraculous. In 1972, the US Congress changed federal policy to guarantee renal replacement therapy to anyone with kidney failure. With this change, dialysis "death panels" were disbanded.

Almost 50 years after the dialysis law was enacted, nephrology has taken the lead once again.

ASN continues to move forward on its commitment to dismantle systemic racism in nephrology. These are complex issues that can limit the ability of nephrologists and kidney health professionals to provide optimal care to patients or to reach their full career potential.

Taking part in the 9th Annual Kidney Health Advocacy Day, advocates from the American Association of Kidney Patients (AAKP) and ASN are urging their congressional delegations to increase funding for kidney research at the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) to drive new breakthroughs for kidney patients and study the impact of COVID-19 on kidney health and people with kidney diseases.

Advocates from the American Association of Kidney Patients (AAKP) and ASN are calling on Congress to include funding for KidneyX in its annual government funding legislation and advance innovative technologies for kidney patients, such as a wearable or implantable artificial kidney.

In response to a Request for Information (RFI), ASN recently submitted comments to the National Institutes of Health (NIH) with input from the ASN Diversity, Equity, and Inclusion Committee, the ASN Health Care Justice Committee, and the ASN Policy and Advocacy Committee.

Last month, ASN and NKF asserted that race should not be included in kidney function estimating equations and that a suitable approach be put in its place that is accurate; representative for all regardless of race, ethnicity, age, or sex; not differentially produce bias, inaccuracy, or inequalities; and be standardized across the United States. Producing such a national standard depends on coordinating efforts to replace the existing equations for estimating kidney function with a suitable approach.

Today, the Journal of the American Society of Nephrology (JASN) and the American Journal of Kidney Diseases (AJKD) published the interim report of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease.

Office of the President, American Society of Nephrology

An unprecedented collaboration between the White House, the Centers for Disease Control, the American Society of Nephrology, and dialysis organizations across the United States resulted in this historic action.